Session » Patient Outcomes, Preferences, and Attitudes Poster III

Date: Tuesday, November 7, 2017

Time: 9:00AM-11:00AM

Meeting: 2017 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2257

Assessing the Impact of a Digital Health Coaching Program for Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2244

Can Achieving Remission Improve Work Ability and Quality of Life in Early Rheumatoid Arthritis (RA) Patients? a Prospective Cohort Study

9:00AM-11:00AM: Abstract Number: 2260

Communication Strategies Are Highly Important to Avoid Nocebo Effect When Performing Non-Medical Switch from Originator Product to Biosimilar Product: Danish Results from Applying the Parker Model a Qualitative 3-Step Research Model

9:00AM-11:00AM: Abstract Number: 2254

Disability (HAQ) and Quality of Life (SF-12) As Related to Adherence and Health Literacyin Patients with Rheumatoid Arthritis – the Trace-Study

9:00AM-11:00AM: Abstract Number: 2248

Function, Pain, Fatigue, and Participation Are the Primary Contributors to the Patient Global Assessment in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2267

Health Related Quality of Life in Lupus: Self-Management- a Modifiable Predictor

9:00AM-11:00AM: Abstract Number: 2246

Impact of Patient Education Tool to Increase Cardiovascular Risk Konwledge, Attitudes, and Behaviors in Patietns with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2249

Influence of Large-Joint Involvement on Patient-Physician Discordance in Global Assessment of Rheumatoid Arthritis Disease Activity Analyzed By Novel Joint Index

9:00AM-11:00AM: Abstract Number: 2252

Initial Validation of Patient-Reported Outcomes Measurement Information System (PROMIS®) in Children with Juvenile Myositis

9:00AM-11:00AM: Abstract Number: 2262

Knowledge, Beliefs and Concerns about Osteoporosis – a Qualitative Synthesis

9:00AM-11:00AM: Abstract Number: 2250

Linguistic Differences in Gout-Related Online Content: A Comparison of Professional Health Literature for Consumers Vs Patients’ Online Discussions of Gout

9:00AM-11:00AM: Abstract Number: 2264

Low Educational Attainment Is Associated with Poor Patient Status in Rheumatoid Arthritis (RA) or Osteoarthritis (OA) at the Initial Rheumatology Visit, with Remarkably Similar Patterns in Either Diagnosis

9:00AM-11:00AM: Abstract Number: 2238

Mapping Paindetect, a Neuropathic Pain Screening Tool, to Patient-Reported Outcomes Measurement Information System (PROMIS) 29 in Patients with Rheumatoid Arthritis: Developing a Neuropathic Pain Scale As a Measure of Treatment Outcome

9:00AM-11:00AM: Abstract Number: 2263

Obesity Independently Associates with Worse Patient Reported Outcomes in Women with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2240

Partnering in Research: Maximizing Benefits & Minimizing Risks in Patient-Researcher Relationships

9:00AM-11:00AM: Abstract Number: 2266

Patient Knowledge, Attitudes, and Beliefs Regarding Biologic Therapies in Ankylosing Spondylitis (AS): Insights from a Large-Scale Analysis of Social Media Platforms

9:00AM-11:00AM: Abstract Number: 2253

Patient’s Self-Monitoring of Disease Activity of Rheumatic Diseases Via Webapp – Study Design, Patient’s Perspective and Recruitment in the First 16 Months of a Swiss Multicentre, Longitudinal Study

9:00AM-11:00AM: Abstract Number: 2242

Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up RA Patients with a Rheumatologist-Patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China

9:00AM-11:00AM: Abstract Number: 2241

Patterns and Outcomes on Disease Activity in Patients with Ankylosing Spondylitis (AS) Using Smart System of Disease Management (SSDM): Analysis of T2T Pattern Shift and Influential Factors

9:00AM-11:00AM: Abstract Number: 2251

Preferences for Physical Activity: A Discrete Choice Experiment in People with Chronic Knee Pain

9:00AM-11:00AM: Abstract Number: 2259

Quality of Life Evaluation in New Onset Juvenile Dermatomyositis Patients from the Printo Trial

9:00AM-11:00AM: Abstract Number: 2258

Real-World Evidence Linking Health-Related Quality of Life to Work Outcomes in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2247

Secondary Fibromyalgia Is Not Associated with Higher Likelihood of Patient-Physician Discordance in Global Assessment in Patients with Osteoarthritis and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2261

Supporting Smoking Cessation in RA and SLE: Identifying Patient-Centered Outcomes

9:00AM-11:00AM: Abstract Number: 2265

Survey on Gout-Related Knowledge and Perception in Inpatient Setting on Hospitalized Patients with Gout

9:00AM-11:00AM: Abstract Number: 2256

Temporal Increases in Side Effect Concerns of Osteoporosis Medications Among Women with Previous Fractures

9:00AM-11:00AM: Abstract Number: 2245

The Effects of Structural Damage on Functional Disability in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2239

The Recall Program: Data from a Multicenter Educational Event on Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2255

Using PROs to Guide Patient-Centered Conversations and Care in Inflammatory Arthritis: The Patient Perspective

9:00AM-11:00AM: Abstract Number: 2237

Work Productivity and Activity Impairment in Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2243

Youtube Videos on Rheumatoid Arthritis: A Qualitative Analysis of Views and Content

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].